NASDAQ
JW (Cayman) Therapeutics Co. Ltd (JWCTF) has a current ratio of 1.45x as of Monday, May 25, 2026. This represents a 71.20% decrease compared to its 12-month average of 5.02x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.